About
Surrogate outcomes, which are indirect measures used to predict the effects of an intervention on a patient's health, can provide valuable insights in studies where direct outcomes are difficult to measure.However, these outcomes need to be properly validated to ensure they are reliable indicators of true clinical benefits or risks.
In the context of rheumatology, where many diseases are chronic and have long-term impacts, surrogate outcomes can play a significant role in clinical trials and observational studies. Our working group has been actively engaged in exploring the use of surrogate outcomes in rheumatology, with a focus on ensuring their validity, reliability, and clinical meaningfulness.
Current Stage in the OMERACT Process
This new methods group is assembling experts to establish standards for validating surrogate endpoints in rheumatology. Their work will support consistent and reliable use of surrogate measures.
Latest Update
Next Meeting
TBD
Meet the Team
Martin Kennedy, New Zealand
Patient Research Partner